Andrew Berens Stock Analyst Profile - Leerink Partners Research Coverage - Stocknear

Andrew Berens

Stock Analyst at Leerink Partners

(4.14)
# 1866
Out of 5,477 analysts
226
Total ratings
Success rate
Average return
41 Stocks
Name Action PT Current % Upside Ratings Updated
CELC Celcuity
Maintains: Outperform
28 60
57.19 4.91% 2 Jul 28, 2025
COGT Cogent Biosciences
Maintains: Outperform
16 18
12.75 41.18% 5 Jul 7, 2025
NUVL Nuvalent
Maintains: Outperform
125 140
80.91 73.03% 2 Jun 24, 2025
ARVN Arvinas
Downgrades: Market Perform
10 9
8.02 12.22% 6 Jun 2, 2025
CMPX Compass Therapeutics
Upgrades: Outperform
4 6
3.54 69.49% 3 Apr 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
9 1
n/a n/a 5 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
880 762
566.08 34.61% 1 Jan 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
33
2.51 1214.74% 1 Dec 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
10 25
15.82 58.03% 10 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
74 96
116.36 -17.5% 1 Oct 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
60 56
36.1 55.12% 11 Sep 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
5 3
n/a n/a 5 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Market Perform
50 97
129.46 -25.07% 24 May 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
78
86.04 -9.34% 12 Dec 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
78 58
58.7 -1.19% 7 Nov 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
13 10
9.1 0% 2 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
35 48
68.44 -29.87% 5 Apr 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
30
25.59 17.23% 11 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
162 141
228.74 -38.36% 19 Feb 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
236 300
184.71 62.42% 11 Jan 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
37 28
9.22 203.69% 3 Dec 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
78 79
81.18 -2.69% 12 Nov 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
42 27
1.51 1688.08% 7 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Oct 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 30
n/a n/a 4 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
69
n/a n/a 4 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
101 76
n/a n/a 6 Jun 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 23
20.01 14.94% 5 May 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 25
6.6 278.79% 3 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
40
6.5 515.38% 1 Nov 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
28
4.07 587.96% 1 Nov 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
67
2.69 2390.71% 1 Oct 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
20
4.94 304.86% 1 Oct 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
6.43 288.8% 1 Sep 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
12 16
1.47 988.44% 5 May 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
4 3
n/a n/a 6 Nov 6, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Overweight
2000
1.42 140745.07% 2 Sep 7, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
156 146
n/a n/a 3 Mar 1, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
102 18
n/a n/a 2 Sep 22, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
75 50
19 163.16% 5 Sep 22, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
16 8
12.88 -37.89% 7 Jul 14, 2017